These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [On the uricosuric effect of a sulfoxide analogue of phenylbutazone]. JUNGBLUTH H; MARTIN H Chemotherapia (Basel); 1961; 3():487-94. PubMed ID: 14452809 [No Abstract] [Full Text] [Related]
3. Uricosuric activity of suxibuzone, a new phenylbutazone derivative. Erill S; Laporte J Arch Farmacol Toxicol; 1975 Mar; 1(1):43-6. PubMed ID: 1231648 [No Abstract] [Full Text] [Related]
6. Comparison of the uricosuric effect of sulfinpyrazone (anturan) and zoxazolamine (flexin). MONTGOMERY DB; OGRYZLO MA Can Med Assoc J; 1960 Oct; 83(17):885-8. PubMed ID: 13772195 [No Abstract] [Full Text] [Related]
7. [Effects of a uricosuric agent associated with the thermal diuresis treatment on uricemia and the excretion of uric acid in 50 hyperuricemic gout patients. Comparison of the action in patients with simple gout and trophic gout]. MUGLER A Rein Foie; 1961 4th Trimest; 2():147-60. PubMed ID: 14476992 [No Abstract] [Full Text] [Related]
8. Biochemical properties of anti-inflammatory drugs. XII. Inhibition of urate binding to human albumin by salicylate and phenylbutazone analogues and some novel anti-antiflammatory drugs. Whitehouse MW; Kippen I; Klinenberg JR Biochem Pharmacol; 1971 Dec; 20(12):3309-20. PubMed ID: 5132879 [No Abstract] [Full Text] [Related]
9. A potent new uricosuric agent, the sulfoxide metabolite of the phenylbutazone analogue, G-25671. BURNS JJ; YU TF; RITTERBAND A; PEREL JM; GUTMAN AB; BRODIE BB J Pharmacol Exp Ther; 1957 Mar; 119(3):418-26. PubMed ID: 13417097 [No Abstract] [Full Text] [Related]
10. Effect of a phenylbutazone analog (4-[phenylthioethyl]-1, 2-diphenyl 3, 5-pyrazolidinedione) on urate clearance and other discrete renal functions in gouty subjects; evaluation as uricosuric agent. YU TF; PATON BC; CHENKIN T; BURNS JJ; BRODIE BB; GUTMAN AB J Clin Invest; 1956 Apr; 35(4):374-85. PubMed ID: 13306779 [No Abstract] [Full Text] [Related]
11. [Ketophenylbutazone, its metabolism and its effect on the uric acid content in the blood and urine]. SIBLIKOVA O; LAVICKA J; VACHEK G; TESAREK B; VITULOVA O; CERNA M Arzneimittelforschung; 1961 Dec; 11():1106-8. PubMed ID: 13912488 [No Abstract] [Full Text] [Related]
12. [CLINICAL STUDY OF 6 CASES OF ARTHRITIS]. ISHIKAWA K; SATO T; HARA Y; HIROKAWA M; NAGAMINE Y; KAIZU T Sogo Rinsho; 1964 Feb; 13():352-61. PubMed ID: 14136576 [No Abstract] [Full Text] [Related]
14. [Uricosuric effect of a phenylbutazone derivative, cetophenylbutazone]. Mugler A Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):33-9. PubMed ID: 5549166 [No Abstract] [Full Text] [Related]
15. [CASE OF CHRONIC TOPHOCEOUS GOUT]. ITO H; OKAZAKI M; AKAOKA I; KOYAMA S Iryo; 1963 Dec; 17():736-40. PubMed ID: 14123823 [No Abstract] [Full Text] [Related]
16. [EFFECT OF PHENYLBUTAZONE ON THE URICEMIA OF SUBJECTS TREATED WITH CHLOROTHIAZIDE]. MORDEGLIA F; BASTAROLI J; FERNANDEZGARCIA E Sem Med; 1963 Jun; 122():1506-7. PubMed ID: 14070550 [No Abstract] [Full Text] [Related]
17. [Effect of pyrasanone on uric-acid metabolism as revealed by rapid fructose infusion]. Procaccio P Clin Ter; 1977 Oct; 83(2):151-61. PubMed ID: 579339 [No Abstract] [Full Text] [Related]
18. Sulphinpyrazone in the treatment of arthritis associated with hyperuricaemia. GLICK EN Proc R Soc Med; 1961 May; 54(5):423-6. PubMed ID: 13706053 [No Abstract] [Full Text] [Related]
19. [On uricosuric therapy of gout]. GAMP A Med Klin; 1960 Jul; 55():1320-3. PubMed ID: 13826253 [No Abstract] [Full Text] [Related]
20. [Apropos of a new uricosuric]. DEROUX J J Belge Med Phys Rhumatol; 1959; 14():196-200. PubMed ID: 13816065 [No Abstract] [Full Text] [Related] [Next] [New Search]